C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/89 (2006.01) A61K 31/444 (2006.01) A61P 11/06 (2006.01) A61P 29/00 (2006.01) C07D 213/70 (2006.01) C07D 213/71 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2372426
The invention encompasses the novel compound of Formula (I) useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). The invention also encompasses pharmaceutical compositions and methods for treatment.
L'invention concerne un nouveau composé de formule (I), utile dans le traitement de maladies, telles que l'asthme, par l'augmentation du taux d'adénosine-3',5'-monophosphate cyclique (AMPc) au moyen de l'inhibition de phosphodiestérase IV (PDE 4). L'invention concerne également des compositions pharmaceutiques et des méthodes de traitement.
Ducharme Yves
Frenette Richard
Prescott Sylvie
Merck Frosst Canada & Co./merck Frosst Canada & Cie
Merck Frosst Canada Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Heterosubstituted pyridine derivatives as pde 4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterosubstituted pyridine derivatives as pde 4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterosubstituted pyridine derivatives as pde 4 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1584533